287 related articles for article (PubMed ID: 28008916)
21. The death receptor Fas (CD95/APO-1) mediates the deletion of T lymphocytes undergoing homeostatic proliferation.
Fortner KA; Budd RC
J Immunol; 2005 Oct; 175(7):4374-82. PubMed ID: 16177078
[TBL] [Abstract][Full Text] [Related]
22. NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes.
Dudley E; Hornung F; Zheng L; Scherer D; Ballard D; Lenardo M
Eur J Immunol; 1999 Mar; 29(3):878-86. PubMed ID: 10092091
[TBL] [Abstract][Full Text] [Related]
23. Isolation of Lipid Rafts Through Discontinuous Sucrose Gradient Centrifugation and Fas/CD95 Death Receptor Localization in Raft Fractions.
Gajate C; Mollinedo F
Methods Mol Biol; 2017; 1557():125-138. PubMed ID: 28078589
[TBL] [Abstract][Full Text] [Related]
24. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
25. Impact of human CD95 mutations on cell death and autoimmunity: a model.
Seyrek K; Ivanisenko NV; Wohlfromm F; Espe J; Lavrik IN
Trends Immunol; 2022 Jan; 43(1):22-40. PubMed ID: 34872845
[TBL] [Abstract][Full Text] [Related]
26. Autoimmunity. The Fas track.
Rathmell JC; Goodnow CC
Curr Biol; 1995 Nov; 5(11):1218-21. PubMed ID: 8574572
[No Abstract] [Full Text] [Related]
27. Surfactant protein D delays Fas- and TRAIL-mediated extrinsic pathway of apoptosis in T cells.
Djiadeu P; Kotra LP; Sweezey N; Palaniyar N
Apoptosis; 2017 May; 22(5):730-740. PubMed ID: 28168327
[TBL] [Abstract][Full Text] [Related]
28. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death.
Muppidi JR; Siegel RM
Nat Immunol; 2004 Feb; 5(2):182-9. PubMed ID: 14745445
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance.
Hsu AP; Dowdell KC; Davis J; Niemela JE; Anderson SM; Shaw PA; Rao VK; Puck JM
Genet Med; 2012 Jan; 14(1):81-9. PubMed ID: 22237435
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis in a Fas-resistant, T-cell receptor-sensitive human leukaemic T-cell clone.
Delehanty LL; Payne JA; Farrow SN; Brown R; Champion BR
Immunology; 1997 Mar; 90(3):383-7. PubMed ID: 9155645
[TBL] [Abstract][Full Text] [Related]
31. FAS and RAS related Apoptosis defects: From autoimmunity to leukemia.
Meynier S; Rieux-Laucat F
Immunol Rev; 2019 Jan; 287(1):50-61. PubMed ID: 30565243
[TBL] [Abstract][Full Text] [Related]
32. Selective involvement of the Fas (CD95)/Fas ligand pathway in bone marrow B cell progenitors.
Laouar Y; Vasseur F; Moreau G; Garcia C; Pasqualetto V; Waché AC; Ezine S
Eur J Immunol; 2000 May; 30(5):1402-9. PubMed ID: 10820387
[TBL] [Abstract][Full Text] [Related]
33. Cellular interactions in the lpr and gld models of systemic autoimmunity.
Sobel ES
Adv Dent Res; 1996 Apr; 10(1):76-80. PubMed ID: 8934931
[TBL] [Abstract][Full Text] [Related]
34. CD137-induced apoptosis is independent of CD95.
Michel J; Pauly S; Langstein J; Krammer PH; Schwarz H
Immunology; 1999 Sep; 98(1):42-6. PubMed ID: 10469232
[TBL] [Abstract][Full Text] [Related]
35. Ceramide enables fas to cap and kill.
Cremesti A; Paris F; Grassmé H; Holler N; Tschopp J; Fuks Z; Gulbins E; Kolesnick R
J Biol Chem; 2001 Jun; 276(26):23954-61. PubMed ID: 11287428
[TBL] [Abstract][Full Text] [Related]
36. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.
Rieux-Laucat F; Magérus-Chatinet A; Neven B
J Clin Immunol; 2018 Jul; 38(5):558-568. PubMed ID: 29911256
[TBL] [Abstract][Full Text] [Related]
37. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
Ashany D; Savir A; Bhardwaj N; Elkon KB
J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
[TBL] [Abstract][Full Text] [Related]
38. Clinical effects of mutations to CD95 (Fas): relevance to autoimmunity?
de Villartay JP; Rieux-Laucat F; Fischer A; Le Deist F
Springer Semin Immunopathol; 1998; 19(3):301-10. PubMed ID: 9540158
[No Abstract] [Full Text] [Related]
39. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model.
Nagata S
J Hum Genet; 1998; 43(1):2-8. PubMed ID: 9609991
[TBL] [Abstract][Full Text] [Related]
40. Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively.
Tóth R; Szegezdi E; Molnár G; Lord JM; Fésüs L; Szondy Z
Eur J Immunol; 1999 Feb; 29(2):383-93. PubMed ID: 10064053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
